Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
73.6M
-
Shares change
-
-504K
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
-$12.2M
-
Put/Call ratio
-
0.11
-
Number of buys
-
182
-
Number of sells
-
-124
-
Price
-
$40.29
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2024
369 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q2 2024.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.6M shares
.
Largest 10 shareholders include BlackRock Inc. (11.1M shares), VANGUARD GROUP INC (7.38M shares), Capital World Investors (3.67M shares), STATE STREET CORP (2.57M shares), ArrowMark Colorado Holdings LLC (2.5M shares), FRED ALGER MANAGEMENT, LLC (2.17M shares), JENNISON ASSOCIATES LLC (1.97M shares), CITADEL ADVISORS LLC (1.81M shares), Champlain Investment Partners, LLC (1.63M shares), and Bellevue Group AG (1.54M shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.